Pneumococcal Disease Prevention and Treatment:
The Critical Role of Pulmonary Medicine
Please join the National Foundation for Infectious Diseases (NFID) and MedscapeCME for an interactive Town Hall addressing the unmet needs and knowledge gaps related to pneumococcal disease prevention and treatment in adults.
In an era of rising antibiotic resistance and evolving epidemiology, the timely prevention and treatment of pneumococcal disease is becoming increasingly important. Pulmonologists and other clinicians specializing in pulmonary medicine are in a unique position to interact and direct the care of numerous at-risk patient populations. The potential benefits and evidence-based significance of disease prevention and treatment modalities will be examined, including the burden of pneumococcal infection, shifting epidemiological patterns, diagnosis, judicious treatment in the face of antibiotic resistance, and steps to prevent the spread of pneumococcal disease.
This Town Hall is presented in an interactive format, encouraging attendees' participation throughout the program. In addition, the activity will be videotaped and made available for online viewing at a later date.
Where: |
AXA Equitable Studios 787 Seventh Avenue New York, NY 10019 (between 51st and 52nd Streets) |
Date: |
Saturday, December 5, 2009 |
Time: |
9:00 AM – 11:00AM Please join us at 8:30 AM for breakfast. |
Please note that this live event will be videotaped and that portions will be presented online on http://cme.medscape.com/pulmonarymedicine.
George Washington University School of Medicine
Chief, Pulmonary Clinic
Washington Hospital Center Pulmonary and Critical Care Medicine
Washington, DC
Seattle, Washington
University of Connecticut School of Medicine
Director, Center for Bronchiectasis Care
University of Connecticut Medical Center
Farmington, Connecticut
University of Texas Health Science Center
San Antonio, Texas
- Compare the burden and prevalence of pneumococcal disease among specific pulmonary medicine patient populations including patients with chronic lung disease, immune deficiency, or advanced age
- Outline steps to diagnose pneumococcal disease in special patient populations
- Outline strategies for pneumococcal disease prevention
- Considering the changing epidemiology of Streptococcus pneumoniae and antibiotic resistance, design a
guideline- and evidence-based treatment plan for pneumococcal disease in patients with chronic lung disease, immune deficiency, or advanced age
The National Foundation for Infectious Diseases (NFID) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide Continuing Medical Education (CME) for physicians. NFID takes responsibility for the content, quality, and scientific integrity of this CME activity.
NFID designates this educational activity for a maximum of 2.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Please notify Medscape at 370 Seventh Avenue, Suite 1101, New York, NY, 10001, 212-417-9562, a minimum of 10 working days in advance of the event if a reasonable accommodation for a disability is needed.
